Aimee Shepherd

Suggest Changes
  • Citations Per Year
Learn More
BACKGROUND There is a need for hepatitis C virus (HCV) therapies with excellent efficacy across genotypes and in diverse populations. Part A of the C-CREST-1 and C-CREST-2 trials led to the selection(More)
  • 1